InsidersTradesSigma
Track the KURA ONCOLOGY INC stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). The latest transaction was filed on 18 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: MOLLIE VANESSA LEONI. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Kura Oncology Inc is a biopharmaceutical company focused on developing treatments for cancer. It employs targeted approaches to address various types of malignant tumors.